(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 16.33% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.49%.
Astrana Health's revenue in 2026 is $2,896,455,000.On average, 13 Wall Street analysts forecast ASTH's revenue for 2026 to be $227,911,792,335, with the lowest ASTH revenue forecast at $196,671,722,010, and the highest ASTH revenue forecast at $248,119,333,320. On average, 8 Wall Street analysts forecast ASTH's revenue for 2027 to be $254,142,193,725, with the lowest ASTH revenue forecast at $214,402,572,735, and the highest ASTH revenue forecast at $284,875,668,315.
In 2028, ASTH is forecast to generate $242,940,799,140 in revenue, with the lowest revenue forecast at $233,371,768,590 and the highest revenue forecast at $250,089,427,845.